Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
HR 3222, Department of Defense Appropriations for FY08; Title IV; Research, Development, Test and Evaluation; issues related to nanotechnology enabled defense research. HR 2641 and S 1751, Energy and Water Development Appropriations for FY08; issues related to nanotechnology enabled fuel cell research.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2007 · year_end · YA
National Defense Authorization; Title II; Research, Development, Test and Evaluation; issues related to nanotechnology enabled defense research.
HR 3222, Department of Defense Appropriations for FY08; Title IV; Research, Development, Test and Evaluation; issues related to nanotechnology enabled defense research. HR 2641 and S 1751, Energy and Water Development Appropriations for FY08; issues related to nanotechnology enabled fuel cell research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
HR 3222, Department of Defense Appropriations for FY08; Title IV; Research, Development, Test and Evaluation; issues related to nanotechnology enabled defense research. HR 2641 and S 1751, Energy and Water Development Appropriations for FY08; issues related to nanotechnology enabled fuel cell research.
HR 3222, Department of Defense Appropriations for FY08; Title IV; Research, Development, Test and Evaluation; issues related to nanotechnology enabled defense research. HR 2641 and S 1751, Energy and Water Development Appropriations for FY08; issues related to nanotechnology enabled fuel cell research.
HR 3222, Department of Defense Appropriations for FY08; Title IV; Research, Development, Test and Evaluation; issues related to nanotechnology enabled defense research. HR 2641 and S 1751, Energy and Water Development Appropriations for FY08; issues related to nanotechnology enabled fuel cell research.
To designate the Federal building and United States courthouse located at 300 Quarropas Street in White Plains, New York, as the "Charles L. Brieant, Jr. Federal Building and United States Courthouse".
Client: NANOSYS · Firm: K&L GATES, LLP
HR 3222, Department of Defense Appropriations for FY08; Title IV; Research, Development, Test and Evaluation; issues related to nanotechnology enabled defense research. HR 2641 and S 1751, Energy and Water Development Appropriations for FY08; issues related to nanotechnology enabled fuel cell research.
To designate the Federal building and United States courthouse located at 300 Quarropas Street in White Plains, New York, as the "Charles L. Brieant, Jr. Federal Building and United States Courthouse".
Client: INTEGRATED NANO-TECHNOLOGIES · Firm: K&L GATES, LLP
HR 3222, Department of Defense Appropriations for FY08; Title IV; Research, Development, Test and Evaluation; issues related to biological terror weapons detection.
To designate the Federal building and United States courthouse located at 300 Quarropas Street in White Plains, New York, as the "Charles L. Brieant, Jr. Federal Building and United States Courthouse".
Client: NANOSYS · Firm: K&L GATES, LLP
HR 3222, Department of Defense Appropriations for FY08; Title IV; Research, Development, Test and Evaluation; issues related to nanotechnology enabled defense research. HR 2641 and S 1751, Energy and Water Development Appropriations for FY08; issues related to nanotechnology enabled fuel cell research.
Biodefense and Pandemic Vaccine and Drug Development Act of 2006
Client: CANGENE CORPORATION · Firm: K&L GATES, LLP
HR 5533, S 2564, and S 3678, BioShield II legislation. Monitor legislation regarding biodefense vaccines and therapeutics, and preparation for possible pandemic. Discuss possible changes to the provisions of S 2564 and S 3678 to address procurement concerns.
HR 5533, S 2564, and S 3678, BioShield II legislation. Monitor legislation regarding biodefense vaccines and therapeutics, and preparation for possible pandemic. Discuss possible changes to the provisions of S 2564 and S 3678 to address procurement concerns.
Department of Veterans Affairs Claims Backlog Reduction Act of 2002
Client: CANGENE CORPORATION · Firm: K&L GATES, LLP
HR 5533, S 2564, and S 3678, BioShield II legislation. Monitor legislation regarding biodefense vaccines and therapeutics, and preparation for possible pandemic. Discuss possible changes to the provisions of S 2564 and S 3678 to address procurement concerns.
CANGENE CORPORATION via K&L GATES, LLP
2007 · year_end · YY
Monitor legislation regarding biodefense vaccines, biodefense therapeutics, and pandemic preparedness (bill not yet introduced).
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
2007 · year_end · YY
National Defense Authorization; Title II; Research, Development, Test and Evaluation; issues related to nanotechnology enabled defense research.
HR 3222, Department of Defense Appropriations for FY08; Title IV; Research, Development, Test and Evaluation; issues related to nanotechnology enabled defense research. HR 2641 and S 1751, Energy and Water Development Appropriations for FY08; issues related to nanotechnology enabled fuel cell research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
INTEGRATED NANO-TECHNOLOGIES via K&L GATES, LLP
2007 · year_end · YY
HR 3222, Department of Defense Appropriations for FY08; Title IV; Research, Development, Test and Evaluation; issues related to biological terror weapons detection.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
INTEGRATED NANO-TECHNOLOGIES via K&L GATES, LLP
2007 · mid_year · MM
Seek federal appropriations for biological terror weapons detection.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
CANGENE CORPORATION via K&L GATES, LLP
2007 · mid_year · MM
Monitor legislation regarding biodefense vaccines, biodefense therapeutics, and pandemic preparedness. Discuss possible legislation addressing procurement processes for Project BioShield.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
2007 · mid_year · MM
Appropriations for nanotechnology enabled chemical defense and solar energy research.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CANGENE CORPORATION via K&L GATES, LLP
2006 · year_end · YY
HR 5533, S 2564, and S 3678, BioShield II legislation. Monitor legislation regarding biodefense vaccines and therapeutics, and preparation for possible pandemic. Discuss possible changes to the provisions of S 2564 and S 3678 to address procurement concerns.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), SENATE
CANGENE CORPORATION via K&L GATES, LLP
2006 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, SENATE